Adam Brown, MD, finds varied ways to share information about rheumatology. “If my educational content is fun and accessible, then hopefully we can catch a few more people and get them excited about it.”
Vasculitis or Vasculopathy?
In considering the cause of aneurysms, dissections, stenoses or occlusions in the large- or medium-sized vessels, it is appropriate to include vasculitis in the differential diagnosis. However, in addition to atherosclerosis, there are a range of less common vasculopathic disease entities that should also be considered.
Infective Endocarditis Can Mimic Systemic Autoimmune Conditions
Infective endocarditis (IE) can look very similar to small vessel vasculitis; however, immunosuppressing this patient could have devastating consequences. Learn how to distinguish between IE and its autoimmune mimics.
Clinical Characteristics of Sarcoidosis in an Asian Population
Ethnicity influences the epidemiology and clinical phenotype of sarcoidosis; however, data on clinical manifestations of sarcoidosis in Asians are relatively limited. In this article, rheumatologist Patompong Ungprasert, MD, discusses the results of a 14-year, single center study from Thailand.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Bisphosphonates and Atypical Femur Fractures in Osteoporosis
Atypical femoral fractures (AFF) are related to long-term therapy with bisphosphonates in the setting of osteoporosis. This case study reviews the diagnosis and treatment of the condition.
Predicting Major Adverse Cardiac Events in Patients With Arthritis
Since patients with chronic systemic inflammatory states may be at increased risk of developing cardiovascular (CV) disease, the ability to predict which patients with RA or OA that are most likely to experience a major cardiac adverse event (MACE) may help rheumatologists risk stratify these patients early.
COVID-19 and the Rheumatologist: What Have We Learned?
The medical community has learned a lot about COVID-19 in the last 12 months; however, several questions remain. In this article, rheumatologist Cassandra Calabrese, DO, discusses what is known and not known about COVID-19 infection and vaccination in patients with immune-mediated inflammatory diseases.
Chronic Glucocorticoid Use Found to Be 5x More Likely in Black Patients With Systemic Lupus Erythematosus
Data analysis reveals that Black patients with systemic lupus erythematosus (SLE) are 5x more likely to use chronic glucocorticoids than white patients. Healthcare access may play a role.
Recognizing Noninfectious Autoimmune Scleritis
When assessing a patient for “red-eye” with severe ocular pain, rheumatologists should have a high index of suspicion for scleritis. In this article, rheumatologist Rula Hajj-Ali, MD, discusses how to alleviate pain and prevent complications in inflammatory eye disease.
Patients Report Positive Experiences With Patient-Reported Outcome Measures in Rheumatology Clinics
Patient reported outcomes measures (PROMS) are very important in rheumatology, as clinical tests may not be indicative of a patient’s quality of life. A new study examines the patient experience of these measures.